According to another study conducted by the American Chemical Society, microbes present in our gut affect the onset of diseases throughout the body. The study has found a way to use chemical compounds to avoid the rise of particular microbes in the digestive tract linked to diseases without causing any injury to other organisms.
Based on a recent studies, changes in those intestinal florae or microbiome may play a part in giving rise to certain ailments such as allergies, asthma, cancer, diabetes, obesity, autism and multiple sclerosis.
Antibiotic scan help restrain the microbiome because it can clear some of the organisms which contribute to a healthy microbiome, but germs which replace the microbiome can sometimes cause more harm than good.
To solve the issues, the group has also examined using probiotics and fecal transplant. Some investigators investigated by taking a look at the microbiome to improve health. Researchers to help fill in the gap used chemical substances to target and interrupt metabolic processes of participants of Bacteroides genus.
Bacteroides genus is bacteria within the gut and is linked to the onset of Type 1 diabetes.
The analysis has found that acarbose (a drug used in the treatment of diabetes) significantly interrupted the action of a group of proteins involved in Starch Utilization System.
The team has discovered that as a result, the bacteria cannot grow and acarbose has been specific. It had similar results on other Bacteroides bacteria, but no or little impact on other types of microbes.